HomeEducationEducation CoursesTreatment Resistant Depression: Advances in Evaluation and Management (September 2025)

Treatment Resistant Depression: Advances in Evaluation and Management (September 2025)

Event Date(s): Sep 2, 2025 - 12:00am to Nov 10, 2025 - 11:59pmAvailable Credits: 12.50 AMA PRA Category 1 Credit™ 12.50 Nursing Contact Hours 12.50 Social Workers 12.50 Participation 12.50 Psychologists CE Credit Register For This Course

Course Details

Registration Deadline: September 15, 2025

There is a significant unmet need for optimal assessment and management of treatment-resistant depression (TRD), which is a common and challenging clinical condition in terms of management.

This course outlines the advances in the assessment and clinical management of treatment-resistant depression (TRD). This course intends to provide the learners with an array of effective treatment strategies for TRD including psychopharmacological approaches, psychotherapeutic interventions, ketamine, neuromodulation treatments including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), and emerging treatments such as deep brain stimulation (DBS), psychedelics, and photobiomodulation treatments.   

Course materials are available beginning September 2, 2025 and all coursework must be completed by November 10, 2025.

Pricing

Registration Deadline: September 15, 2025

Physicians and Doctoral-level Professionals: $445.00
Other Professionals: $345.00

Cancellation Policy

Refunds will be issued for cancellation requests made during the first week of the course, but an administrative fee of $25.00 will be deducted from your refund.  Cancellation requests made during the second week will receive a credit toward a future offering of the same course.  No refunds or credits will be granted after September 15, 2025.

Q&A Schedule

Week Start Date

Date of Q&A

Time of Q&A

      Faculty Name

Week 1: 9/2/2025

TBD Dr. Amit Chopra

Week 2: 9/8/2025

TBD Dr. David Mischoulon  

Week 3: 9/15/2025

TBD Dr. Lauren Fischer

Week 4: 9/22/2025

TBD Dr. Cristina Cusin

Week 5: 9/29/2025

TBD Dr. Joan Camprodon 

Week 6: 10/6/2025

TBD Dr. Ananda Pandurangi

Week 7: 10/13/2025

TBD Dr. Michael Kritzer-Cheren 

Week 8: 10/20/2025

TBD Dr. Franklin King 

Course Summary

Available Credits:12.50 AMA PRA Category 1 Credit™ 12.50 Nursing Contact Hours 12.50 Social Workers 12.50 Participation 12.50 Psychologists CE Credit
Course Topic:Cognitive Behavioral Therapy, PTSD, Essentials
Course Format:Online CBT Course, Online Course
Target Audience:

This program is intended for:

  • Psychiatrists
  • Primary care physicians
  • Family practice physicians
  • Psychologists
  • Nursing professionals
  • Residents & fellows
  • Social workers
Event Starts: Sep 2, 2025 - 12:00am
Event Ends: Nov 10, 2025 - 11:59pm
Cost: $445.00

Learning Objectives

By the end of this program, participants will be able to:

  1. Describe advances in the assessment and neurobiology of Treatment-Resistant Depression (TRD)
  2. Analyze the evidence-based advanced medication strategies in the management of TRD
  3. Assess the role of evidence-based psychotherapeutic treatments in management of TRD
  4. Assess the efficacy and safety of Ketamine and glutamatergic agents in TRD
  5. Assess the efficacy, safety, and advancements in Transcranial Magnetic Stimulation (TMS) for the management of TRD
  6. Analyze the efficacy and safety of Vagus Nerve Stimulation (VNS)
  7. Analyze the efficacy and safety of Deep Brain Stimulation (DBS) in TRD
  8. Describe the evidence supporting the role of Photobiomodulation in treating TRD
  9. Describe the evidence supporting the role of Psychedelics in treating TRD

We have a dedicated staff member who is available by phone 5 days per week between 8 am and 5 pm by calling 866-644-7792 or email at mghcme@mgh.harvard.edu. All inquiries will be dealt with in a timely  (within one business day) and professional manner. Requests for credits or refunds will be reviewed by the Director of the Division of Professional and Public Education, Massachusetts General Hospital. Please refer to our cancellation policy for additional information.”